Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

SS Pharm./Torii developing new antiallergic agent

March 13, 1997

Novel LT biosynthesis inhibitor discovered by Abbott

March 11, 1997

Fluticasone + loratadine for seasonal allergic rhinitis

March 10, 1997

Spiros products progressing through pipeline

March 10, 1997

New PDE III/IV inhibitor described

March 10, 1997

HLE inhibitors from P&U

March 5, 1997

Antiallergic compounds disclosed by Meiji Seika

Feb. 28, 1997

PathoGenesis to seek approval for tobramycin

Feb. 27, 1997

Positive clinical results for inhaled indomethacin

Feb. 27, 1997

Mediator release inhibitors described by French investigators

Feb. 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
Research grants support early clinical trials of ALS treatments
BioWorld Science
The ALS Association has announced the recipients of its 2025 Hoffman ALS Clinical Trial Awards. These research grants, worth up to $1 million each, support...